Versions Compared

Old Version 1

changes.mady.by.user Joe Ben Clark

Saved on

compared with

New Version Current

changes.mady.by.user Soumya Rajesh

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
SDS
Home on the CDISC Website
  • SDS Home on the CDISC Wiki (Access may be restricted to SDS Team Members)
  • 2015 CDISC Technical Plan
    • Leadership Team
    • Kristin Kelly
    • Soumya Rajesh
    • Maria Sekac
    • Dianna DiRusso (Project Manager)
    SDS Sub-team Leaders

    Team leaders are listed in the SDS Subteam Tracker.

    SDS Team Liaisons to the GGG

    • Gary Walker

    • Michael Wise

    • Dave Scocca

    Deliverables
    • Study Data Tabulation Model Implementation Guide (SDTMIG): Human Clinical Trials
    • SDTMIG Conformance Rules

    • SDTMIG for Associated Persons (AP)

    • SDTMIG for Medical Devices (MD)

    • Metadata Submission Guidelines (MSG) for SDTMIG

    • Oncology Supplements

    • Questionnaires, Ratings, Scales (QRS) Supplements





    .

    Team Mission

    The SDS team develops and maintains standards for representing study data from human clinical trials and other research collaborations. The SDS team seeks continuous improvement and strives to increase the value of standardized study data for greater interoperability and accessibility by academic researchers, healthcare organizations, sponsors, and global health authorities.

    Scope

    The SDS team scope focuses on SDTM implementation guides for human clinical trial data. Each implementation guide (and its associated SDTM) describes the organization, structure, and format of the standardized data to support use by academic researchers, healthcare organizations, sponsors, and/or global health authorities.

    Operating Model
    • Working meetings to plan for future projects and content for industry stakeholders
    • A predictable and open forum for SDS team members to raise concerns/issues, provide feedback, identify cross-standard discrepancies (e.g., CDASH, CT), propose solutions, support development of content, and aid in the review and disposition of content for publication
    • Communicate across and manage all associated SDS sub-teams
    • Provide the Global Governance Group (GGG) updates to the wider SDS team members
    • Aid in on-boarding and mentoring SDS volunteers by providing a transparent and inclusive development culture
    Stakeholders
    • Regulatory Authorities (e.g., U.S. FDA, PMDA)
    • Standards & Related Organizations (e.g., HL7, LOINC, WHO, UMC, PhUSE)
    • Pharmaceutical/Biotech, Medical Devices, etc.
    • Contract Research Organizations (CROs)
    • Technology Vendors
    • Consultants, Programmers, Statisticians, and other related Subject Matter Experts
    • Academic and Scientific Communities
    • Healthcare Institutions
    Cross-Team Collaborations

    The SDS team works closely across CDISC teams to ensure consistency, clarity, and to support development requirements of SDS deliverables.

    A list of cross-team collaborations (and SDS subteams) are listed on the SDS Home page.

    Additional Resources

    *Links are accessible to CDISC Volunteers only.

    .

    Leadership Team

    1. Dan Godoy (Co-Lead)
    2. Barrie Nelson (Co-Lead)
    3. Diane Wold
    4. Wayne Kubick
    5. Amy Palmer
    6. Fred Wood

    SDTM Area Leads

    Findings NEC

    Randall Austin & Jan Hess

    Interventions, Events and FA

    Janet Reich & Madhavi Vemuri

    Lab Findings

    Joyce Hernandez & VACANT

    Oncology

    Barrie Nelson, Melanie Paules & Amy Adyanthaya

    Clinical Outcome Assessments & Classifications

    Gary Cunningham & Steve Kopko, Bess LeRoy, Jon Neville

    Special Purpose

    Tom Guinter & Richard Lewis

    Trial Design & IE

    Diane Wold & VACANT

    Business Rules

    Stetson Line

    SDTM Experts

    Gail Stoner

    Gary Walker

    Madhavi Vemuri

    Cross-Team Liaisons

    FDA: Ron Fitzmartin & Helena Sviglin

    SDS Volunteers: Naveed Khaja

    Controlled Terminology: Bernice Yost

    Devices: Carey Smoak

    Team Mission

    To develop and maintain a standard model and implementation guides that support more consistent and effective integration, aggregation, and submission of tabulation data from human clinical trials to facilitate FDA reviews and increase the value of collected research data.

    Scope

    The SDS Team develops standards for the submission of tabulation data from human clinical trials.  Since its inception, the SDS Team has worked to develop data domain models to support the Safety Domains listed in the 1999 FDA Guidance Documents from CDER & CBER, and continues to develop new or enhanced domain models through Study Data Tabulation Model (SDTM), as well as its drug- and biologics-focused Implementation Guide (SDTMIG).

    The SDS team maintains the SDTMIG, Metadata Submission Guideline, and SDTMIG-AP, in alignment with the CDISC Strategy, by organizing its constituent members into relevant sub-teams to deliver domain models that meet growing data standardization needs from FDA, as well as key therapeutic-area-focused and collaborative organizations such as TransCelerate BioPharma.

     

    The SDS Team is also looking to directly support C-FAST Therapeutic Area Standards products.

    2015 Product Goals

    The SDS Team will agree and implement its 2015 SDS Team - Project Delivery Plan, targeting to deliver:

    • Strong contribution to future updates to the Study Data Tabulation Model (SDTM)
    • An update to the Study Data Tabulation Model Implementation Guide (SDTMIG v3.3)
    • An update to the Metadata Submission Guideline (MSG v1.0)
    • The SDTMIG Rules Guidance (v1.0)
    • Intermediate provisional domain models (more to be defined)

    Other Major Project(s)

    The SDS Team will begin a project to load SDTM content into SHARE in 2015, and will also initiate the creation and implementation of several new domains, enhancements, and/or corrections to previously published sections, and other incremental content targeted for inclusion on the next release of the SDTMIG (v 3.3). Domains may be released in batches for review and provisional use prior to 3.3.

    These updates may be originated from previously existing plans, or as a direct result of Therapeutic Area Project needs.  Calls for volunteers will be issued to create SDTM Domain Development sub-teams.

    Stakeholders/Constituency

    • Regulatory Authorities
    • Standards Development Organizations
    • Pharmaceutical Sponsors
    • Medical Devices, Diagnostics

    Contract Research Organizations & Consultants

    Collaborations

    The SDS Team works closely with CDISC Teams who utilize or leverage the SDTM standard to develop their own IGs (e.g., SDTM Governance, SEND, ADaM, Devices, CDASH, PGx, XML Technologies).

    The SDS Team is also a strong contributor to BRIDG, SHARE, and TA Project Teams

    Operating Model & Meetings

    • Full team is divided into sub-teams to deliver one or more components from the 2015 SDS Team - Project Delivery Plan to effectively maintain the SDTM, SDTMIG, and SDTMIG-AP
    • Sub-teams set own meeting schedule, and mechanism to report progress through their SDTM Area Lead(s)
    • SDTM Area Leads ensure consistency across SDTM Sections/domains under their care, and report maintenance progress up to SDS LT
    • SDS LT regularly engages with SDTM Area Leads to share CDISC Updates & Review deliverables against agreed 2015 SDS Team - Project Delivery Plan
    • Key meetings on Mondays 11am-12:30pm EDT
      • 1st & 3rd Monday SDS LT
      • 2ND & 4TH Monday – SDS LT, SDTM Area Leads & SDTM Experts and Liaisons
    Quarterly meetings w/ full SDS Team, including volunteers